SUPPORT Tools for evidence-informed health Policymaking (STP) 5: Using research evidence to frame options to address a problem

被引:31
|
作者
Lavis, John N. [1 ,2 ]
Wilson, Michael G. [3 ,4 ]
Oxman, Andrew D. [5 ]
Grimshaw, Jeremy [6 ]
Lewin, Simon [5 ,7 ]
Fretheim, Atle [5 ,8 ]
机构
[1] McMaster Univ, Dept Clin Epidemiol & Biostat, Ctr Hlth Econ & Policy Anal, 1200 Main St West,HSC 2D3, Hamilton, ON L8N 3Z5, Canada
[2] McMaster Univ, Dept Polit Sci, Hamilton, ON L8N 3Z5, Canada
[3] Hlth Res Methodol PhD Program, Hamilton, ON L8N 3Z5, Canada
[4] Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada
[5] Norwegian Knowledge Ctr Hlth Serv, N-0130 Oslo, Norway
[6] Ottawa Hlth Res Inst, Clin Epidemiol Program, Ottawa, ON K1Y 4E9, Canada
[7] Med Res Council South Africa, Hlth Syst Res Unit, Tygerberg, South Africa
[8] Univ Oslo, Inst Gen Practice & Community Med, Sect Int Hlth, Fac Med, Oslo, Norway
来源
关键词
Research Evidence; Local Cost; Local Evidence; Stakeholder View; Programme Option;
D O I
10.1186/1478-4505-7-S1-S5
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Policymakers and those supporting them may find themselves in one or more of the following three situations that will require them to characterise the costs and consequences of options to address a problem. These are: I. A decision has already been taken and their role is to maximise the benefits of an option, minimise its harms, optimise the impacts achieved for the money spent, and ( if there is substantial uncertainty about the likely costs and consequences of the option) to design a monitoring and evaluation plan, 2. A policymaking process is already underway and their role is to assess the options presented to them, or 3. A policymaking process has not yet begun and their role is therefore to identify options, characterise the costs and consequences of these options, and look for windows of opportunity in which to act. In situations like these, research evidence, particularly about benefits, harms, and costs, can help to inform whether an option can be considered viable. In this article, we suggest six questions that can be used to guide those involved in identifying policy and programme options to address a high-priority problem, and to characterise the costs and consequences of these options. These are: I. Has an appropriate set of options been identified to address a problem? 2. What benefits are important to those who will be affected and which benefits are likely to be achieved with each option? 3. What harms are important to those who will be affected and which harms are likely to arise with each option? 4. What are the local costs of each option and is there local evidence about their cost-effectiveness? 5. What adaptations might be made to any given option and could they alter its benefits, harms and costs? 6. Which stakeholder views and experiences might influence an option's acceptability and its benefits, harms, and costs?
引用
收藏
页码:269 / 275
页数:10
相关论文
共 18 条
  • [1] Effects of policy options for human resources for health: an analysis of systematic reviews
    Chopra, Mickey
    Munro, Salla
    Lavis, John N.
    Vist, Gunn
    Bennett, Sara
    [J]. LANCET, 2008, 371 (9613): : 668 - 674
  • [2] SUPPORT Tools for Evidence-informed Policymaking in health 6: Using research evidence to address how an option will be implemented
    Fretheim, Atle
    Munabi-Babigumira, Susan
    Oxman, Andrew D.
    Lavis, John N.
    Lewin, Simon
    [J]. HEALTH RESEARCH POLICY AND SYSTEMS, 2009, 7
  • [3] SUPPORT Tools for Evidence-informed Policymaking in health 18: Planning monitoring and evaluation of policies
    Fretheim, Atle
    Oxman, Andrew D.
    Lavis, John N.
    Lewin, Simon
    [J]. HEALTH RESEARCH POLICY AND SYSTEMS, 2009, 7
  • [4] Medicine sellers and malaria treatment in sub-Saharan Africa: What do they do and how can their practice be improved?
    Goodman, Catherine
    Brieger, William
    Unwin, Alasdair
    Mills, Anne
    Meek, Sylvia
    Greer, George
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (06): : 203 - 218
  • [5] Kingdon JW., 1995, Agendas, Alternatives, and Public Policies, V2nd edn.
  • [6] Lavis John, 2005, J Health Serv Res Policy, V10 Suppl 1, P35, DOI 10.1258/1355819054308549
  • [7] SUPPORT Tools for evidence-informed health Policymaking (STP) Introduction
    Lavis, John N.
    Oxman, Andrew D.
    Lewin, Simon
    Fretheim, Atle
    [J]. HEALTH RESEARCH POLICY AND SYSTEMS, 2009, 7
  • [8] SUPPORT Tools for evidence-informed health Policymaking (STP) 4: Using research evidence to clarify a problem
    Lavis, John N.
    Wilson, Michael G.
    Oxman, Andrew D.
    Lewin, Simon
    Fretheim, Atle
    [J]. HEALTH RESEARCH POLICY AND SYSTEMS, 2009, 7 : 262 - 268
  • [9] SUPPORT Tools for evidence-informed health Policymaking (STP) 7: Finding systematic reviews
    Lavis, John N.
    Oxman, Andrew D.
    Grimshaw, Jeremy
    Johansen, Marit
    Boyko, Jennifer A.
    Lewin, Simon
    Fretheim, Atle
    [J]. HEALTH RESEARCH POLICY AND SYSTEMS, 2009, 7 : 381 - 387
  • [10] Lewin S A, 2005, Cochrane Database Syst Rev, pCD004015